About Us

MEFTAL-SPAS® is a flagship brand from Blue Cross Laboratories, recommended by doctors for managing colic and dysmenorrhea.

Trusted by patients.
Recommended by doctors.

The MEFTAL-SPAS® product range was born from the vision of Blue Cross Laboratories to make highly effective and trusted medicines accessible. Since 1980, it has been a trusted antispasmodic-analgesic brand preferred in managing colic and dysmenorrhea.

The MEFTAL-SPAS® Journey

1980

Blue Cross Laboratories was established with a vision to deliver affordable, high-quality healthcare products, thus laying the foundation for MEFTAL-SPAS®.

1982

The MEFTAL-SPAS® brand was launched, setting the groundwork for what was to become India’s most trusted No.1 prescribed antispasmodic-analgesic brands.

2018

We launched #WhySufferSilently, our award-winning awareness campaign on dysmenorrhea.

2026

MEFTAL-SPAS® grew into India's No. 1 prescribed antispasmodic-analgesic, trusted by doctors and patients nationwide.

The MEFTAL-SPAS® Growth Story

Since its launch in early 1980s, MEFTAL-SPAS® has grown into India's Top INR 300 brand in 2026, reflecting sustained trust from doctors and patients across India. This growth mirrors decades of consistent quality, clinical credibility, and deep-rooted relationships within the healthcare community.

The MEFTAL-SPAS® Milestones

Over the years, we have earned accolades that highlight our commitment to excellence and consistency in quality.

MEFTAL-SPAS®
No. 1 Prescribed

Antispasmodic
Analgesic-Antispasmodic
Brand in India

Data source: IQVIA MAT Jul'26 Unit Sales

MEFTAL-SPAS®
India’s
Most Trusted

Antispasmodic-Analgesic Brand

MEFTAL-SPAS®
19th Most Prescribed

Brand in India

Source: IQVIA RX July'19 & TSA Aug'19